RGNX logo

REGENXBIO (RGNX) Operating Expenses

Annual Operating Expenses

$321.16 M
+$102.00 K+0.03%

31 December 2023

RGNX Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$73.89 M
+$6.13 M+9.05%

30 September 2024

RGNX Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGNX Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.0%-9.3%
3 y3 years+34.9%-0.2%
5 y5 years+165.9%+53.6%

RGNX Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+34.9%-12.5%+19.2%
5 y5 yearsat high+165.9%-12.5%+53.6%
alltimeall timeat high+3551.6%-12.5%+3341.4%

REGENXBIO Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$73.89 M(+9.1%)
June 2024
-
$67.75 M(-7.3%)
Mar 2024
-
$73.10 M(-2.4%)
Dec 2023
$321.16 M(+0.0%)
$74.88 M(-8.1%)
Sept 2023
-
$81.49 M(-2.5%)
June 2023
-
$83.61 M(+3.0%)
Mar 2023
-
$81.18 M(+6.4%)
Dec 2022
$321.06 M(+24.2%)
$76.33 M(-9.6%)
Sept 2022
-
$84.46 M(+2.7%)
June 2022
-
$82.23 M(+5.4%)
Mar 2022
-
$78.03 M(+25.8%)
Dec 2021
$258.53 M(+8.6%)
$62.00 M(-16.2%)
Sept 2021
-
$74.02 M(+14.9%)
June 2021
-
$64.44 M(+11.0%)
Mar 2021
-
$58.08 M(-10.4%)
Dec 2020
$238.09 M(+35.3%)
$64.84 M(-4.1%)
Sept 2020
-
$67.60 M(+25.8%)
June 2020
-
$53.72 M(+3.4%)
Mar 2020
-
$51.94 M(+7.5%)
Dec 2019
$175.99 M
$48.30 M(+0.4%)
Sept 2019
-
$48.10 M(+12.3%)
DateAnnualQuarterly
June 2019
-
$42.83 M(+16.5%)
Mar 2019
-
$36.76 M(+3.6%)
Dec 2018
$120.77 M(+42.8%)
$35.48 M(+29.0%)
Sept 2018
-
$27.51 M(-7.7%)
June 2018
-
$29.81 M(+6.6%)
Mar 2018
-
$27.96 M(+47.0%)
Dec 2017
$84.57 M(+22.6%)
$19.02 M(-13.4%)
Sept 2017
-
$21.96 M(+8.2%)
June 2017
-
$20.30 M(-12.8%)
Mar 2017
-
$23.29 M(+6.6%)
Dec 2016
$68.97 M(+136.0%)
$21.84 M(+16.4%)
Sept 2016
-
$18.76 M(+11.5%)
June 2016
-
$16.83 M(+45.7%)
Mar 2016
-
$11.55 M(+27.4%)
Dec 2015
$29.22 M(+232.3%)
$9.06 M(+10.1%)
Sept 2015
-
$8.23 M(+12.0%)
June 2015
-
$7.35 M(+60.3%)
Mar 2015
-
$4.58 M(+42.1%)
Dec 2014
$8.79 M(-16.4%)
$3.23 M(+50.3%)
Sept 2014
-
$2.15 M
Dec 2013
$10.53 M
-

FAQ

  • What is REGENXBIO annual total operating expenses?
  • What is the all time high annual operating expenses for REGENXBIO?
  • What is REGENXBIO annual operating expenses year-on-year change?
  • What is REGENXBIO quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for REGENXBIO?
  • What is REGENXBIO quarterly operating expenses year-on-year change?

What is REGENXBIO annual total operating expenses?

The current annual operating expenses of RGNX is $321.16 M

What is the all time high annual operating expenses for REGENXBIO?

REGENXBIO all-time high annual total operating expenses is $321.16 M

What is REGENXBIO annual operating expenses year-on-year change?

Over the past year, RGNX annual total operating expenses has changed by +$102.00 K (+0.03%)

What is REGENXBIO quarterly total operating expenses?

The current quarterly operating expenses of RGNX is $73.89 M

What is the all time high quarterly operating expenses for REGENXBIO?

REGENXBIO all-time high quarterly total operating expenses is $84.46 M

What is REGENXBIO quarterly operating expenses year-on-year change?

Over the past year, RGNX quarterly total operating expenses has changed by -$7.60 M (-9.32%)